Daewon Pharmaceutical Co., Ltd.
003220.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
449
Cost of Revenue
233
Gross Profit
215
Gross Margin
48.0%
Operating Income
21
Operating Margin
4.7%
Net Income
11
Net Margin
2.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
34
EBITDA Margin
7.6%
2023
12/31/2023
Revenue
395
Cost of Revenue
205
Gross Profit
191
Gross Margin
48.2%
Operating Income
24
Operating Margin
6.1%
Net Income
18
Net Margin
4.5%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
36
EBITDA Margin
9.1%
2022
12/31/2022
Revenue
359
Cost of Revenue
181
Gross Profit
178
Gross Margin
49.7%
Operating Income
32
Operating Margin
9.0%
Net Income
24
Net Margin
6.7%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
46
EBITDA Margin
12.9%
2021
12/31/2021
Revenue
266
Cost of Revenue
133
Gross Profit
132
Gross Margin
49.8%
Operating Income
15
Operating Margin
5.5%
Net Income
5
Net Margin
2.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
28
EBITDA Margin
10.5%
2020
12/31/2020
Revenue
231
Cost of Revenue
107
Gross Profit
124
Gross Margin
53.8%
Operating Income
18
Operating Margin
7.8%
Net Income
13
Net Margin
5.7%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
30
EBITDA Margin
13.1%